Use of PARP Inhibitors in Breast Cancer: Implications for Pharmacy Practice

September 9, 2022

Video

About 1 in 8 women in the United States will develop breast cancer in their lifetime. Overall mortality for breast cancer has decreased over the years with the addition of complex treatment, such as PARP inhibitors. The webcast discusses this class of medications and see how they fit into the treatment paradigm for breast cancer.

Related Content

The Impact of Substance Misuse During the COVID-19 Pandemic

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777